A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 28397878)

Published in Sci Rep on April 11, 2017

Authors

Biao Huang1, Liang Wang2, Yi Zhang1, Jue Zhang1, Qiuhua Zhang2, Hualong Xiao2, Bin Zhou1, Zhuxing Sun2, Ya-Nan Cao3, Yu Chen4, Zhigang Hu2,4, Huiming Sheng3

Author Affiliations

1: Jiangsu Institute of Nuclear Medicine, Wuxi, 214063, China.
2: Wuxi People's Hospital affiliated to Nanjing Medical University, Wuxi, 214023, China.
3: Tongren Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
4: The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.

Articles cited by this

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81

An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant (2011) 4.19

Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol (2011) 2.72

Membranous nephropathy: recent travels and new roads ahead. Kidney Int (2010) 2.68

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med (2011) 2.64

Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int (2004) 2.44

Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol (2012) 2.21

The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant (2009) 1.90

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int (2013) 1.84

Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant (2012) 1.80

Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta (2013) 1.68

The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis (2010) 1.60

PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med (2010) 1.53

Membranous nephropathy. J Nephrol (2007) 1.43

Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice? Neth J Med (2012) 1.42

The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant (2010) 1.34

Mammalian phospholipase A2: phospholipase A2 receptor. Biol Pharm Bull (2004) 1.18

Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol (2011) 1.08

Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol (2009) 1.02

Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Nefrologia (2014) 1.00

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol (2014) 0.98